Screener
Evolus EOLS D&A
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Evolus in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Evolus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053468
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 57,052 | 56,675 | 109,033 | 113,315 |
| Research and development | 1,892 | 1,837 | 4,132 | 4,049 |
| Revaluation of contingent royalty obligation payable to Evolus Founders | 1,250 | (3,914) | 1,236 | (1,763) |
| Depreciation and amortization | 1,529 | 932 | 3,067 | 1,756 |
| Total operating expenses | 61,723 | 55,530 | 117,468 | 117,357 |
| Loss from operations | (4,543) | (10,210) | (11,391) | (25,382) |
| Other income (expense): | ||||
| Interest income | 296 | 479 | 581 | 1,189 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Evolus's D&A?
- Evolus (EOLS) reported D&A of $1.53M in Q2 2026.
- How has Evolus's D&A changed year-over-year?
- Evolus's D&A increased by 64.1% year-over-year, from $932K to $1.53M.
- What is the long-term trend for Evolus's D&A?
- Over 4 years (2021 to 2025), Evolus's D&A has grown at a -6.2% compound annual growth rate (CAGR), from $5.62M to $4.35M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Evolus's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude